<VariationArchive VariationID="1701743" VariationName="NM_015335.5(MED13L):c.319dup (p.Glu107fs)" VariationType="Duplication" Accession="VCV001701743" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-04" DateCreated="2022-08-24" MostRecentSubmission="2022-08-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1694133" VariationID="1701743">
      <GeneList>
        <Gene Symbol="MED13L" FullName="mediator complex subunit 13L" GeneID="23389" HGNC_ID="HGNC:22962" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="115958576" stop="116277693" display_start="115958576" display_stop="116277693" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="116396380" stop="116714990" display_start="116396380" display_stop="116714990" Strand="-" />
          </Location>
          <OMIM>608771</OMIM>
          <Haploinsufficiency last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MED13L">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MED13L">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015335.5(MED13L):c.319dup (p.Glu107fs)</Name>
      <CanonicalSPDI>NC_000012.12:116111503:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="116111503" stop="116111504" display_start="116111503" display_stop="116111504" variantLength="1" positionVCF="116111503" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="116549308" stop="116549309" display_start="116549308" display_stop="116549309" variantLength="1" positionVCF="116549308" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E107fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.116549309dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.116549309dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.116111504dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.116111504dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023366.1" sequenceAccession="NG_023366" sequenceVersion="1" change="g.170683dup">
            <Expression>NG_023366.1:g.170683dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015335.5" sequenceAccession="NM_015335" sequenceVersion="5" change="c.319dup" MANESelect="true">
            <Expression>NM_015335.5:c.319dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056150.1" sequenceAccession="NP_056150" sequenceVersion="1" change="p.Glu107fs">
            <Expression>NP_056150.1:p.Glu107fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2137899583" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015335.5(MED13L):c.319dup (p.Glu107fs) AND Cardiac anomalies - developmental delay - facial dysmorphism syndrome" Accession="RCV002276497" Version="1">
        <ClassifiedConditionList TraitSetID="23771">
          <ClassifiedCondition DB="MedGen" ID="C4225208">Cardiac anomalies - developmental delay - facial dysmorphism syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-09-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-24" MostRecentSubmission="2022-08-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="23771" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34580" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiac anomalies - developmental delay - facial dysmorphism syndrome</ElementValue>
                <XRef ID="MONDO:0014773" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRFACD</ElementValue>
                <XRef Type="MIM" ID="616789" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17588" />
                <XRef ID="17588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12999" />
                <XRef ID="12999" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="369891" DB="Orphanet" />
              <XRef ID="C4225208" DB="MedGen" />
              <XRef ID="MONDO:0014773" DB="MONDO" />
              <XRef Type="MIM" ID="616789" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5013193" SubmissionDate="2022-08-17" DateLastUpdated="2022-08-23" DateCreated="2022-08-23">
        <ClinVarSubmissionID localKey="NM_015335.4:c.319dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002564330" DateUpdated="2022-08-23" DateCreated="2022-08-23" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift de novo variant c.319dup (p.Glu107GlyfsTer11) identified in the MED13L gene has not been reported in affected individuals in the literature. The variant causes a frameshift and creates a premature stop codon downstream. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is absent from gnomAD(v3) database suggesting it is not a common benign variant in the populations represented in that database. Based on the available evidence, the frameshift de novo variant c.319dup (p.Glu107GlyfsTer11) identified in the MED13L gene is reported as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/hhfhf6ms/nygc_assertion_criteria_2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002300" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015335.4:c.319dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616789" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-NYCKidSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB11941775</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5013193" TraitType="Disease" MappingType="XRef" MappingValue="616789" MappingRef="OMIM">
        <MedGen CUI="C4225208" Name="Cardiac anomalies - developmental delay - facial dysmorphism syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5013193" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002300" MappingRef="HP">
        <MedGen CUI="C0026884" Name="Mutism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5013193" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5013193" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

